Cel­gene pays $50M to tie up with four big can­cer re­search cen­ters

The top re­search in­sti­tu­tions have played a lead­ing role in the de­vel­op­ment of a full slate of new can­cer ther­a­pies in re­cent years. And now Cel­gene has forked out $50 mil­lion to set up a con­sor­tium that will bring to­geth­er some of those in­sti­tu­tions’ top in­ves­ti­ga­tors to­geth­er for the Big Biotech’s work in the field.

Cel­gene hand­ed out $12.5 mil­lion each to the Abram­son Can­cer Cen­ter at the Uni­ver­si­ty of Penn­syl­va­nia, The Her­bert Irv­ing Com­pre­hen­sive Can­cer Cen­ter at Co­lum­bia Uni­ver­si­ty Med­ical Cen­ter, the Sid­ney Kim­mel Com­pre­hen­sive Can­cer Cen­ter at Johns Hop­kins, and The Tisch Can­cer In­sti­tute at the Ic­ahn School of Med­i­cine at Mount Sinai to cre­ate the group.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.